ADN - Advent Technologies Holdings, Inc.
NASDAQ
->
Utilities
->
Utilities—Renewable
Boston,
United States
Type: Equity
ADN price evolution
ADN
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3.1 | $3.01 | $2.83 | $3.2 |
| Inventory | $13.9 | $15.16 | $14.86 | $12.62 |
| Total current assets | $23.5 | $31.47 | $39 | $49.5 |
| Long term investments | ||||
| Property, plant & equipment | $28 | $24.34 | $24.19 | $21.99 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $55.4 | $63.9 | $80.85 | $89.59 |
| Current liabilities | ||||
| Accounts payable | $6.1 | $6.54 | $5.4 | $3.48 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $12.8 | $13.38 | $14.91 | $13.67 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $22.8 | $23.84 | $25.78 | $25.44 |
| Shareholders' equity | ||||
| Retained earnings | -$153.4 | -$141.58 | -$119.75 | -$107.76 |
| Other shareholder equity | -$2.8 | -$2.27 | -$2.27 | -$2.6 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.02 | $0.52 | ||
| Short term investments | ||||
| Net receivables | $3.2 | $9.19 | $1 | $0.6 |
| Inventory | $12.62 | $6.96 | $0.1 | |
| Total current assets | $49.5 | $97.35 | $0.58 | $0.58 |
| Long term investments | ||||
| Property, plant & equipment | $21.99 | $8.58 | $0.2 | $0.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $93.34 | $225.43 | ||
| Total investments | ||||
| Total assets | $89.59 | $163.03 | $93.92 | $226.01 |
| Current liabilities | ||||
| Accounts payable | $3.48 | $3.64 | $0.35 | $0.03 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $13.67 | $18.87 | $3.18 | $1.28 |
| Long term debt | $0.14 | |||
| Total noncurrent liabilities | $117.18 | $17.96 | ||
| Total debt | ||||
| Total liabilities | $25.44 | $32.83 | $120.36 | $19.25 |
| Shareholders' equity | ||||
| Retained earnings | -$107.76 | -$33.42 | -$79.98 | $20.23 |
| Other shareholder equity | -$2.6 | -$1.27 | -$0 | $201.76 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.4 | $2.23 | $1.26 | |
| Cost of revenue | ||||
| Gross Profit | $0.06 | -$0.04 | -$0.26 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $11.15 | $11.11 | $12.84 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.57 | -$0.44 | -$0.66 | |
| Interest expense | -$0.03 | -$0.03 | ||
| Net income | ||||
| Net income | -$11.47 | -$11.15 | -$4.1 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1.63 | $0.7 | $0.12 | |
| Operating income | -$1.63 | -$0.7 | -$0.12 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.2 | $1.07 | $0.11 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$100.21 | $21.51 | $0.31 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$3.98 | -$3.12 | -$1.01 | -$25.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.04 | $141.5 | ||
| Effect of exchange rate | -$1.13 | -$0.75 | -$0.16 | -$0.86 |
| Change in cash and equivalents | -$37.32 | -$33.23 | -$20.48 | $79.24 |
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 |
|---|---|---|---|---|
| Net income | -$100.21 | $21.51 | $0.31 | |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3.2 | -$0.63 | -$0.11 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$25.56 | $132.93 | $0.27 | -$220.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $141.5 | -$130.22 | $221.52 | |
| Effect of exchange rate | -$0.86 | |||
| Change in cash and equivalents | $79.24 | -$0.5 | -$0.37 | $0.89 |
News
Fundamentals
| Market cap | $10.56M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 62.10M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 43.31% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.84 |
| Quick ratio | 0.75 |